Lymphocyte to Procalcitonin Ratio in Covid-19 Patients
- Conditions
- COVID-19
- Registration Number
- NCT06620159
- Lead Sponsor
- Suleyman Demirel University
- Brief Summary
The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age.
- Detailed Description
The lymphocyte/CRP ratio has been studied many times in covid-19 patients and has been proven to be an indicator of mortality as well as poor prognosis. In this study, the role of the lymphocyte/procalcitonin ratio in predicting the hospitalization status of patients, detection of findings on CT, need for mechanical ventilation, mortality and survival is aimed to be determined. The lymphocyte/procalcitonin ratio was found to be the strongest predictor of mortality and poor prognosis, especially in patients over 65 years of age. The auc value, PPV and specificity of the lymphocyte/procalcitonin ratio were higher than the lymphocyte/CRP ratio.
Recruitment & Eligibility
- Status
- ACTIVE_NOT_RECRUITING
- Sex
- All
- Target Recruitment
- 535
- Covid19 PCR test positive
- Pregnancy Under 18 years old
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method outcome 30 days The relationship between lymphocyte/procalcitonin ratio and 30-day mortality was analyzed.
- Secondary Outcome Measures
Name Time Method
Trial Locations
- Locations (1)
Süleyman demirel üniversitesi tıp fakültesi
🇹🇷Isparta, Turkey